• Science
  • Pipeline
  • About Us
  • News & Media
  • Resources
  • Investors
  • Contact Us
TheraCryf
  • Science
  • Pipeline
  • About Us
  • News & Media
  • Resources
  • Investors
  • Contact Us
Mobile close button Mobile toggle button

STEM Trial: SFX-01 in the Treatment and Evaluation of Metastatic breast cancer, presented at the San Antonio Breast Cancer Symposium 2018

steve | 4 December 2018
Categories:

Post navigation

← SFX-01 targets STAT3 signalling to inhibit stem-like cells in breast cancer patient-derived xenograft tumours, presented at the UK Interdisciplinary Breast Cancer Symposium 2018
Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases →
footer logo
Copyright© 2025
ICO Reg: ZB396415
Company Number: 09246681
  • Website Privacy Policy and Cookie Policy
  • Sitemap
Twitter Twitter linkedin linkedin
Get in touch